Inventor · disambiguated record
Claudia Schurmann
Also filed as: SCHURMANN CLAUDIA
6 granted patents·2 pending applications·13 citations·filing 2018–2025
75Inventor score
Files withREGENERON PHARMA8
Top patents by PatentIndex Score
8 records- 0194US11702700B2Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variationREGENERON PHARMA·Filed 2021·Granted Jul 18, 2023·4 cites·27 claims
- 0292US10961583B2Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variationREGENERON PHARMA·Filed 2018·Granted Mar 30, 2021·9 cites·29 claims
- 0384US12286677B2Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variationREGENERON PHARMA·Filed 2023·Granted Apr 29, 2025·0 cites·14 claims
- 0474US2025305050A1Inhibition Of HSD17B13 In The Treatment Of Liver Disease In Patients Expressing The PNPLA3 I148M VariationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0563US11512309B2Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2021·Granted Nov 29, 2022·0 cites·13 claims
- 0662US11767526B2Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2020·Granted Sep 26, 2023·0 cites·11 claims
- 0756US11845989B2Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitorsREGENERON PHARMA·Filed 2020·Granted Dec 19, 2023·0 cites·4 claims
- 0850US2022089664A1Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) InhibitorsREGENERON PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Claudia Schurmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →